Not Yet RecruitingNot Applicable

Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study

Singapore1,000 participantsStarted 2025-07

Plain-language summary

A registry of patients from the Asia-Pacific region with PFO and ischemic stroke, designed to study the characteristics, investigations, treatment and outcomes using real-world data.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject has experienced acute ischemic stroke or transient ischemic attack
✓. Subject is screened with presence of PFO (right-to-left shunt) on appropriate cardiac imaging (transthoracic echocardiography and/or transesophageal echocardiography) or transcranial Doppler bubble study
✓. Age ≥18 years

Exclusion criteria

✕. Stroke mimics, haemorrhagic stroke or cerebral venous thrombosis
✕. Subjects with less than 3 months of follow up

What they're measuring

Recurrent ischemic stroke or transient ischemic attack event within 1 year

Timeframe: Within 1 year

Trial details

NCT IDNCT06983795

SponsorNational University Hospital, Singapore

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-12

Contact for this trial

Benjamin Y Tan, MBBS

+65 6779 5555 benjamin_yq_tan@nuhs.edu.sg

View on ClinicalTrials.gov More Ischemic Stroke trials